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Abstract  59 
Aim: There is uncertainty about the direction and magnitude the associations between parity, breastfeeding and the risk of 60 
coronary heart disease (CHD). We examined the separate and combined associations of parity and breastfeeding practices 61 
with the incidence of CHD later in life among women in a large pan-European cohort study. 62 
Methods: Data were used from EPIC-CVD, a case-cohort study nested within the EPIC prospective study of 520,000 63 
participants from 10 countries. Information on reproductive history was available for 14,917 women, including 5,138 incident 64 
cases of CHD. Using Prentice-weighted Cox regression stratified by country, we calculated hazard ratios (HRs) and 95% 65 
confidence intervals (CIs) for CHD, after adjustment for age, study centre, and several socioeconomic and biological risk 66 
factors.  67 
 68 
Results: Compared with nulliparous women, the adjusted HR was 1.19 (95% CI: 1.03-1.38) among parous women; HRs were 69 
higher among women with more children (e.g., adjusted HR: 1.04, 1.27-3.27, for women with ≥5 children). Compared with 70 
women who did not breastfeed, the adjusted HR was 0.70 (0.50-0.97) among women who breastfed. For childbearing women 71 
who never breastfed, the adjusted HR was 1.27 (0.72-2.24) compared with nulliparous women, whereas for childbearing 72 
women who breastfed the adjusted HR was 0.92 (0.62-1.37).  73 
 74 
Conclusion: Having more children was associated with a higher risk of CHD later in life, whereas breastfeeding was associated 75 
with a lower CHD risk. Women who both had children and breastfed did not have a higher risk of CHD.  76 
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Introduction 77 
Pregnancy is associated with profound changes in the maternal metabolic system, including weight gain, accumulation of 78 
abdominal fat, increased insulin resistance, and higher circulating lipid levels.1, 2 While these metabolic changes of pregnancy 79 
support the growth of the foetus and prepare the mother's body for breastfeeding in the short-term, they may also have a 80 
prolonged effect on maternal risk of cardiovascular diseases (CVD). However, previous studies have reported conflicting 81 
associations on parity (i.e., the number of live children to whom a woman has given birth) and risk of CVD later in life.3-10 82 
Conversely, since the metabolic changes in pregnancy appear to reverse more quickly and more completely with 83 
breastfeeding, it has been proposed that breastfeeding could reduce maternal risk of cardiometabolic diseases.11 Studies 84 
have reported that, compared with women who have never breastfed, women who have breastfed have favourable 85 
cardiometabolic profiles,12, 13 and exhibit a lower burden of subclinical cardiovascular disease.14 There may be a lower risk of 86 
developing metabolic syndrome,15 hypertension,16, 17 and type 2 diabetes18-21 among women who have breastfed for longer 87 
cumulative durations. However, it is uncertain whether there is an association between breastfeeding and incident CVD 88 
outcomes.10, 22-24 Also, while lifetime duration of breastfeeding will be affected by the number of children, it is unknown 89 
whether extended duration of breastfeeding for one child is associated with the same extent of inverse association with CHD 90 
risk as multiple periods of shorter breastfeeding across several pregnancies. Moreover, whether breastfeeding could 91 
compensate for the potential effect of parity on CHD risk has not been examined.  92 
The EPIC (European Prospective Investigation into Cancer and Nutrition)-CVD study provides an opportunity to 93 
address these outstanding issues and to evaluate the separate and combined associations of parity and breastfeeding on the 94 
risk of incident CHD in a large sample of women from diverse European countries.  95 
 96 
Methods 97 
EPIC-CVD is a large, prospective, case-cohort study nested within the European Prospective Investigation into Cancer and 98 
Nutrition (EPIC) study. 25, 26 Briefly, the EPIC study involves 366,521 women and 153,457 men, mostly aged 35–70 years, 99 
recruited by 23 centres in 10 European countries (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, 100 
Sweden, and the United Kingdom) between 1991 and 1999. Participants completed questionnaires on their diet, lifestyle, and 101 
medical history, and data were centralized at the International Agency for Research on Cancer (IARC) in Lyon, France. A 102 
representative random subcohort of 18,249 participants (62% women), stratified by centre, was selected for the EPIC-CVD 103 
project.27 After exclusion of 609 participants with a prior history of myocardial infarction or stroke at baseline, 17,640 104 
subcohort members remained. This study complied with the Declaration of Helsinki; ethical review boards of IARC and all 105 
local institutions where participants had been recruited gave approval for the study, and all participants gave written 106 
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Definition and ascertainment of CHD events 111 
First-time CHD events, whether non-fatal or fatal, as defined by codes 410-414 of the International Classification of Diseases 112 
Ninth Edition (ICD-9), and codes I20-I25 of the Tenth Edition (ICD-10) were the primary study endpoint. Individual centres 113 
used different methods to ascertain first-time non-fatal CHD events, including self-report and linkage with morbidity or 114 
hospital registries. Non-fatal CHD events were further validated by additional review of medical records and/or linkage with 115 
registries.26 Fatal CHD events were generally ascertained through mortality registries. End of follow-up for CHD events varied 116 
between centres and ranged between 2003 and 2010. 117 
 118 
Study population and measurement  119 
Of the 16,504 women in EPIC-CVD who did not have a known history of CHD or stroke at baseline and 14,917 women 120 
provided data on reproductive history. Two EPIC centres (Bilthoven, the Netherlands, and Umea, Sweden) did not assess 121 
parity and breastfeeding history and thus did not contribute to the analyses. Reproductive history, socioeconomic and 122 
lifestyle factors, and medical history were assessed once using a self-administrated questionnaire at study baseline. Trained 123 
health professionals measured blood pressure, weight, height, and waist circumference during a visit to each study centre, 124 
except in the France and Oxford centres where anthropometry was self-reported. Blood pressure measurements were not 125 
available for the Norway, Asturias, and Navarra centres. High blood pressure was defined as self-reported hypertension at 126 
baseline, systolic blood pressure>140 or diastolic blood pressure >90, or self-reported use of hypertension medication. Body 127 
mass index was calculated as weight divided by the square of height in meters. HDL cholesterol and total cholesterol levels, 128 
measured in baseline serum samples using a Roche MODULAR ANALYTICS EVO analyser, were available in all centres except 129 
Norway.  130 
 131 
Statistical analyses 132 
Baseline characteristics for the subcohort by parity were presented as means (standard deviation) or medians (interquartile 133 
range) for continuous variables and as percentages for categorical variables. Cox proportional hazards models, modified for 134 
the case-cohort design using the Prentice method28, were used to estimate hazard ratios and 95% confidence intervals for 135 
first-time CHD by parity and breastfeeding history. Participants contributed only the first CHD outcome (whether non-fatal or 136 
fatal) experienced during follow-up, so fatal events that followed non-fatal events were not included. Given the multilevel 137 
structure of the data, models were first fitted separately within each country before pooling the country-specific estimates by 138 
multivariate random-effects meta-analysis using inverse variance weights. Age was used as the underlying time variable, with 139 
entry time defined as the participant’s age at recruitment, and exit time as the age of first-time CHD, loss-to-follow-up or 140 
censoring at the end of the follow-up, whichever came first. The I2 statistic was used to quantify the percentage of total 141 
variability between countries due to between-country heterogeneity. Parity, defined as the number of live births, was 142 
categorized as nulliparous (reference), 1 child, 2 children, 3 children, 4 children, or 5 or more children. Breastfeeding history 143 
was examined among parous women, comparing women who ever breastfed to women who had never breastfed, and 144 
categorized into groups of lifetime duration of breastfeeding (never [reference], >0-<3 months, 3-<6 months, 6-<12 months, 145 
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12-<23 months, and 23 months or more), and into groups of mean duration of breastfeeding per live-born child (never 146 
[reference], >0-<1 months, 1-<3 months, 3-<6 months, and 6 months or more). Group-specific 95% confidence intervals were 147 
estimated only from the variances that correspond to the amount of information underlying each group (including the 148 
reference group).29 To assess the combined effect of parity and breastfeeding on CHD risk, we also examined the association 149 
between parity, history of breastfeeding and risk of first-time CHD in models including nulliparous women as the reference 150 
group.  151 
Models were adjusted for age at study entry and centre (Model I), and then additionally for level of attained 152 
education, smoking status, and parity (for breastfeeding history only) (Model II), followed by further adjustment for other 153 
confounders and potential mediators  (history of high blood pressure, HDL cholesterol, total cholesterol, history of diabetes 154 
mellitus, and BMI) (Model III). Model III was used as our primary, most conservative, analyses model. To account for the 155 
impact of missing covariate data on our results, we restricted our main analyses to individuals with complete data for all 156 
models. Secondary analyses allowed the set of individuals to vary between models and used all individuals with non-missing 157 
values for the covariates separately for each model. To investigate whether age or number of live births modified the 158 
association between parity or breastfeeding with CHD risk, we calculated the HRs for CHD in women <55 years versus ≥ 55 159 
years of age, and in women with 1 or 2 children versus those with 3 children or more. Statistical interaction was evaluated by 160 
adding a cross-product term to the country-specific regression models and pooling these using random-effects meta-analysis. 161 
In a sensitivity analysis, we excluded women younger than 45 in whom reproductive history may not yet be complete. All 162 
statistical analyses were performed using STATA, version 12.0 (Stata, College Station, TX). 163 
 164 
Results 165 
The baseline characteristics of the 9,985 women in the subcohort with information on reproductive history are shown in 166 
Table 1. The mean (SD) age at entry was 52.7 (9.1) years, 88% of these women were parous, of these 87% had ever breastfed. 167 
Women who were parous had a lower level of attained education, had higher levels of BMI, and were less likely to smoke 168 
than those who were nulliparous. During a median follow-up of 11.1 years (interquartile range 8.0-13.4), 5,138 of 14,890 169 
women developed CHD, of whom 206 were also in the subcohort. Supplementary Table 1 shows the descriptive statistics for 170 
main characteristics by centre.  171 
 172 
Parity and risk of coronary heart disease  173 
Of 12,481 women with complete data, 3,336 developed CHD during follow-up. The HR (95% CI) for CHD in parous versus 174 
nulliparous women was 1.25 (1.07, 1.46) in the age- and country stratified model and attenuated to 1.19 (1.03, 1.38) 175 
following adjustment for potential confounders and mediators (Table 2). The I2 statistic for the multiple-adjusted analyses 176 
was 29% (0%-67%), indicating that there was moderate heterogeneity between countries. Compared to nulliparous women, 177 
the multiple-adjusted HRs for CHD were 1.16 (0.89, 1.51), 1.14 (1.02, 1.28), 1.16 (0.96, 1.41), 1.40 (1.18, 1.66), and 2.03 (1.27, 178 
3.26) for women with 1, 2, 3, 4, or 5 or more children, respectively (Table 2 and Figure 1). Results were similar in analyses 179 
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including the largest set of women with complete data available, irrespective of incomplete data in subsequent models, or 180 
when restricting the analyses to women aged 45 years or older at study entry (Supplementary Tables 2 and 3).  181 
 182 
Breastfeeding history and risk of coronary heart disease  183 
Data on breastfeeding history were available on 12,779 parous women and 4348 CHD events; 8,074 women (2,404 CHD 184 
events) had complete data on all variables. Parous women who had ever breastfed had a multiple-adjusted HR for CHD of 185 
0.70 (95% CI: 0.50, 0.97) compared with parous women who never breastfed (Table 2). There was substantial heterogeneity 186 
between countries; the I2 statistic was 82% (65%-91%). Compared with parous women who had never breastfed, women with 187 
a lifetime duration of breastfeeding of >0-<3 months, 3-<6 months, 6-<12 months, 12-<23 months, or 23 months or more had 188 
a multiple-adjusted HR for CHD of 0.71 (0.59, 0.86), 0.67 (0.57, 0.79), 0.68 (0.55, 0.84), 0.61 (0.52, 0.71), and 0.59 (0.44, 0.79), 189 
respectively (Figure 2 and Table 2). Similar results were obtained in the analyses on the mean duration of breastfeeding per 190 
child and CHD risk (Figure 3 and Table 2). Analyses restricted to women 45 years or older or including women with missing 191 
data on some covariables did not change the findings materially (Supplementary Tables 2 and 3).  192 
 193 
Combination of parity and breastfeeding and risk of coronary heart disease 194 
Analyses of the combination of parity and breastfeeding indicated that parous women who had ever breastfed were at a 195 
similar risk of CHD compared to nulliparous women (HR: 0.92 [0.62, 1.37]; Table 3). There was no significant evidence for a 196 
higher risk of CHD in parous women who had never breastfed (HR: 1.27 [0.72, 2.24]), although power to detect weak effects 197 
was limited. 198 
 199 
Subgroup analyses 200 
Analyses in subgroups of women younger than 55 years versus those 55 years or above at study entry provided no evidence 201 
for a different effect of parity by age, and neither did the association between number of children and risk of CHD differ 202 
between the age groups (Table 4). A history of breastfeeding was associated with similar reductions in risk of CHD in younger 203 
as in older women, and in women with 1 or 2 children as in those with 3 or more children. The associations between lifetime 204 
duration of breastfeeding and duration of breastfeeding per child and CHD risk also did not differ between age groups or by 205 
parity (Table 4).  206 
 207 
Discussion 208 
In this case-cohort analysis, nested within the 10-country EPIC prospective cohort study, we examined the separate and 209 
combined associations of parity and breastfeeding on the risk of incident CHD. Our main findings are threefold.  210 
 211 
First, we report that parous women are at higher risk of CHD as compared to nulliparous women; with the highest risk seen 212 
among women who had the most offspring. These findings, therefore, add to the accumulating evidence that repeated 213 
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pregnancies could result in an accumulation of cardiometabolic changes, including elevated pro-atherogenic lipid levels, 214 
accumulation of abdominal fat, endothelial dysfunction, and increased systemic inflammation,1, 30 that may have permanent 215 
effects on the cardiovascular system, leading to a higher risk of CHD later in life.3-7  216 
 217 
Second, in agreement with previous observations that breastfeeding is associated with lower risk of the metabolic 218 
syndrome,15 hypertension,16, 17 and diabetes,18-21 our study supports the existence of inverse associations between 219 
breastfeeding and CHD risk. Previous studies have reported that prolonged periods of breastfeeding could have beneficial 220 
effects on maternal cardiovascular risk factors, including on lipids, blood pressure, insulin and glucose homeostasis, and body 221 
mass index.12, 31 Our results extend previous work by supporting the possibility of stronger inverse associations between 222 
breastfeeding and CHD risk among women who had longer cumulative lifelong duration of breastfeeding. However, the dose-223 
response curve between breastfeeding and CHD risk requires further investigation, since it may be context-dependent. For 224 
example, a previous study of more than 20,000 Norwegian women reported that breastfeeding was associated with a lower 225 
risk of CVD mortality, potentially in a U-shaped fashion, but only among parous women younger than 65 years at study 226 
baseline.22 Results from the Nurses’ Health Study suggested that the association between lifetime duration of breastfeeding 227 
and risk of incident CHD was characterized by a threshold effect; only women with lifetime duration of two years or more had 228 
a significantly lower risk of incident CHD compared to women who had never breastfed.23 Conversely, while a history of 229 
breastfeeding was associated with a slightly lower risk of fatal CHD in a cohort of 267,400 women from Shanghai, increasing 230 
duration of breastfeeding did not strengthen the association.10 231 
 232 
Third, our study constitutes one of the few available analyses of the combined associations of parity and breastfeeding on the 233 
incidence of CHD. We found that women who both had children and breastfed did not have a higher risk of CHD, which is 234 
consistent with the notion that the physiological changes in pregnancy could reverse more quickly and more completely with 235 
breastfeeding, which in turn may confer cardiovascular protection later in life.11  236 
 237 
Our observations are consistent with the conclusions of previous studies that attempted to disentangle biological processes 238 
related to pregnancy from lifestyle factors related to childrearing by comparing results from men and women within the same 239 
cohort. For example, a study among men from prospective cohorts in the US found no relationship between the number of 240 
children and the paternal risk of CHD,32 whereas there was a positive association between having 6 or more pregnancies and 241 
CHD risk among women from the same cohort.5 A cross-sectional analysis of men and women from the British Women's Heart 242 
and Health Study and the British Regional Heart Study reported that having more offspring was associated with higher body 243 
mass index for both male and female parents, and with more adverse lipid profiles and diabetes in women only.6 However, as 244 
there was a positive association between parity and CHD among women (but not men) in these cohorts, the authors 245 
concluded that the biological effects of pregnancy in women persist into later life.  246 
 247 
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The strengths and potential limitations of our study merit consideration. Our analysis maximized power and efficiency by 248 
conducting a case-cohort analysis of incident CHD in the large prospective EPIC cohort, thereby focusing measurement of 249 
lipids and other biochemical risk factors on the most relevant subset of the cohort. The validity of our findings was enhanced 250 
by our ability to adjust for a range of relevant covariates, and by the robustness of our results to a variety of sensitivity and 251 
subgroup analyses. The generalisability of our findings was enhanced by the inclusion of women from 10 diverse European 252 
countries. However, we cannot discount the possibility that the associations observed in this study were, at least partly, due 253 
to unmeasured or residual confounding. For example, confounding is a major concern in studies of breastfeeding and health 254 
outcomes, because mothers who breastfeed are more likely to engage in other health-promoting behaviours.33-35 255 
Nevertheless, we found that adjustment in our study for several relevant factors did not materially affect the relationships we 256 
observed. Our study had insufficient data to account for CHD risk factors before or during pregnancy that determine 257 
breastfeeding initiation and duration as well as future CHD risk, leaving our results potential liable to “reverse causality”. For 258 
example, women with pre-existing CHD risk factors such as obesity, type 1 diabetes, preeclampsia, or polycystic ovary 259 
syndrome, might be less likely to initiate breastfeeding and or could breastfeed for shorter durations than women without 260 
these CHD risk factors. Because our study involved self-reported information on parity and breastfeeding, information that 261 
was sometimes recalled and recorded decades after childbirth and weaning (with the added limitation that duration of 262 
breastfeeding was recorded in EPIC only for a woman’s first three children and final child), the true strength of any 263 
associations we observed could have been underestimated. Data on the number of children in men was not available, so we 264 
were no able to dissect whether the association between parity and CHD was due to biological effects of childbearing or 265 
factors related to childrearing. Finally, we noted between-country heterogeneity in some of our results, a finding which 266 
requires further investigation. 267 
 268 
In conclusion, this analysis of women from 10 European countries found that having more children was associated with a 269 
higher risk of CHD later in life, whereas breastfeeding was associated with a lower CHD risk. Women who both had children 270 
and breastfed did not have a higher risk of CHD, suggesting the need for studies to determine whether breastfeeding can 271 
compensate for the CHD risk associated with greater parity. 272 
  273 
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Figure legend  
Figure 1: Adjusted hazard ratios (with group-specific 95% confidence intervals) for incident coronary heart disease 
associated with number of live born children.  
The highest category of live born children (5 or more) is plotted at 5.5. 
 
Figure 2: Adjusted hazard ratios (with group-specific 95% confidence intervals) for incident coronary heart disease 
associated with lifetime duration of breastfeeding in parous women.  
Categories are never, 0-<3 months, 3-<6 months, 6-<12 months, 12-<23 months, and 23 months or more. On the x-axis, 
results are placed on the mean lifetime duration of breastfeeding within category. 
Figure 3: Adjusted hazard ratios (with group-specific 95% confidence intervals) for incident coronary heart disease 
associated with mean duration of breastfeeding per live born child.  
Categories are never, 0-<1 months, 1-<3 months, 3-<6 months, and 6 months or more. On the x-axis, results are placed on the 






 Page 14 of 23 
 
Table 1: Baseline characteristics of women in the EPIC-CVD subcohort by parity 
 Overall subcohort Nulliparous Parous 
N (% of overall subcohort) 9,985 1,220 (12.2) 8,765 (87.8) 
Age at study entry, years 52.7 (9.1) 52.7 (10.1) 52.7 (9.0) 
Education level, %    
  None 11.3 7.0 11.9 
  Primary 34.3 23.9 35.8 
  Secondary  15.4 18.2 15.0 
  Tertiary 39.0 50.9 37.4 
Current smoker, % 21.7 25.4 21.1 
History of diabetes, % 2.6 2.3 2.7 
BMI, kg/m
2
 26.1 (4.7) 24.9 (4.3) 26.2 (4.7) 
Systolic blood pressure, mmHg 130.8 (20.0) 129.6 (20.4) 131.0 (19.9) 
Diastolic blood pressure, mmHg 80.3 (10.6) 79.2 (10.4) 80.5 (10.6) 
History of high blood pressure, % 34.3 30.1 34.9 
Total cholesterol, mmol/L 6.0 (1.1) 6.0 (1.2) 6.0 (1.1) 
HDL cholesterol, mmol/L 1.6 (0.4) 1.7 (0.4) 1.6 (0.4) 
Postmenopausal, % 52.7 53.9 52.5 
Age at menopause
Ɨ
 48.5 (4.9) 48.1 (5.3) 48.6 (4.9) 
Number of children*, %    
  1 child - - 14.8 
  2 children - - 47.5 
  ≥3 children - - 37.7 
History of breastfeeding*, % - - 87.2 
Lifetime duration of breastfeeding*, months - - 6.4 (3.0, 13.0) 
Duration of breastfeeding per child*, months - - 3.0 (1.5, 6.0) 
 
Values are mean (standard deviation) or median (25th and 75th percentile) for continuous variables. Ɨ postmenopausal 
women only, *parous women only. 
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Table 2: Hazard ratios (95% confidence intervals) for incident coronary heart disease associated with parity in all women and 
history of breastfeeding in parous women only  
 Model I Model II Model III 
Parity    
  N 12,481 12,481 12,481 
    
Parous (yes vs. no) 1.25 (1.07, 1.46) 1.23 (1.05, 1.43) 1.19 (1.03, 1.38) 
  I
2
 for heterogeneity (95% CI) 40% (0%, 72%) 40% (0%, 72%) 29% (0%, 67%) 
    
Number of children     
   None 1.00 (0.84, 1.19) 1.00 (0.83, 1.20) 1.00 (0.85, 1.18) 
   1 child 1.18 (0.97, 1.43) 1.13 (0.93, 1.38) 1.16 (0.89, 1.51) 
   2 children 1.20 (1.10, 1.32) 1.16 (1.12, 1.20) 1.14 (1.02, 1.28) 
   3 children 1.23 (1.07, 1.41) 1.21 (1.04, 1.41) 1.16 (0.96, 1.41) 
   4 children 1.51 (1.27, 1.79) 1.49 (1.23, 1.79) 1.40 (1.18, 1.66) 
   5 or more children 2.28 (1.51, 3.45) 2.05 (1.31, 3.22) 2.03 (1.27, 3.26) 
    
History of breastfeeding    
  N  8,074 8,074 8,074 
    
Ever breastfed (yes vs. no) 0.68 (0.59, 0.80) 0.61 (0.50, 0.74) 0.70 (0.50, 0.97) 
  I
2
 for heterogeneity 54% (0%, 80%) 62% (12%, 83%) 82% (65%, 91%) 
    
Lifetime duration of breastfeeding     
   Never breastfed 1.00 (0.83, 1.21) 1.00 (0.83, 1.23) 1.00 (0.73, 1.37) 
   >0 to <3 months 0.67 (0.59, 0.77) 0.66 (0.57, 0.77) 0.71 (0.59, 0.86) 
   ≥3 to <6 months 0.70 (0.58, 0.85) 0.69 (0.59, 0.81) 0.67 (0.57, 0.79) 
   ≥6 to <12 months 0.72 (0.61, 0.84) 0.67 (0.57, 0.79) 0.68 (0.55, 0.84) 
   ≥12 to <23 months 0.63 (0.57, 0.70) 0.60 (0.52, 0.70) 0.61 (0.52, 0.71) 
   ≥23 months 0.63 (0.48, 0.83) 0.56 (0.43, 0.73) 0.59 (0.44, 0.79) 
    
Duration of breastfeeding per child     
   Never breastfed 1.00 (0.88, 1.14) 1.00 (0.85, 1.18) 1.00 (0.74, 1.35) 
   >0 to <1 months 0.82 (0.71, 0.95) 0.75 (0.64, 0.89) 0.82 (0.68, 0.98) 
   ≥1 to <3 months 0.73 (0.65, 0.81) 0.71 (0.64, 0.79) 0.70 (0.65, 0.76) 
  ≥3 to <6 months 0.69 (0.57, 0.84) 0.66 (0.57, 0.78) 0.69 (0.60, 0.80) 
   ≥6 months 0.64 (0.53, 0.78) 0.66 (0.54, 0.81) 0.66 (0.57, 0.77) 
Hazard ratios are from Prentice-weighted Cox proportional hazards models stratified by country and with age as timescale. 
Analyses of parity are conducted in all women. Analyses of breastfeeding are conducted in parous women only. 
Model I: Adjusted for age at study entry and centre; Model II: model I + level of attained education, smoking status, and 
number of live born children (for breastfeeding only); Model III: model II + high blood pressure, HDL cholesterol, total 
cholesterol, history of diabetes mellitus, and BMI.  
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Table 3: Hazard ratios (95% confidence intervals) for incident coronary heart disease associated with the combined effects of 





Hazard ratios are from Prentice-weighted Cox proportional hazards models stratified by country and with age as timescale. 
Model I: Adjusted for age at study entry and centre; Model II: model I + level of attained education, smoking status, and 
number of live born children; Model III: model II + high blood pressure, HDL cholesterol, total cholesterol, history of diabetes 
mellitus, and BMI.  
  
 Nulliparous Parous – never 
breastfed 
Parous – ever 
breastfed 
Model I 1.00 [reference] 1.63 (1.26, 2.11) 1.13 (0.95, 1.35) 
Model II 1.00 [reference] 1.50 (1.07, 2.11) 0.91 (0.63, 1.31) 
Model III 1.00 [reference] 1.27 (0.72, 2.24) 0.92 (0.62, 1.37) 
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Table 4: Hazard ratios (95% confidence intervals) for incident coronary heart disease by parity and history of breastfeeding in 
subgroups  
 Age   Parity   
 <55 years 55 years or older P for 
interaction 




Parous (yes vs. no) 1.17 (0.91, 1.52) 1.19 (0.89, 1.60) 0.94 - - - 
       
Number of children       
   1 child 1.37 (0.79, 2.38) 1.07 (0.63, 1.80) 0.76 - - - 
   2 children 1.12 (0.64, 1.96) 1.67 (0.79, 3.53)  - -  
   3 children 1.15 (0.75, 1.77) 1.36 (0.94, 1.96)  - -  
   4 children 1.13 (0.81, 1.57) 1.53 (0.45, 5.19)  - -  
   5 or more children 1.30 (0.91, 1.87) 1.84 (1.20, 2.82)  - -  
       
History of breastfeeding (yes vs. 
no) 0.68 (0.50, 0.93) 0.72 (0.50, 1.04) 0.70 0.66 (0.45, 0.95) 0.67 (0.41, 1.08) 0.91 
       
Lifetime duration of 
breastfeeding  
      
   >0 to <3 months 0.74 (0.49, 1.11) 0.67 (0.41, 1.10) 0.31 0.67 (0.45, 0.99) 0.87 (0.53, 1.41) 0.30 
   ≥3 to <6 months 0.51 (0.35, 0.74) 0.68 (0.40, 1.15)  0.63 (0.42, 0.94) 0.79 (0.51, 1.22)  
   ≥6 to <12 months 0.75 (0.46, 1.22) 0.61 (0.38, 1.01)  0.64 (0.36, 1.14) 0.72 (0.45, 1.17)  
   ≥12 to <23 months 0.54 (0.34, 0.86) 0.60 (0.34, 1.05)  0.61 (0.37, 1.01) 0.65 (0.37, 1.14)  
   ≥23 months 0.55 (0.29, 1.04) 0.55 (0.37, 0.81)  1.09 (0.48, 2.48) 0.62 (0.43, 0.89)  
       
Duration of breastfeeding per 
child  
      
   >0 to <1 months 0.79 (0.54, 1.14) 0.71 (0.44, 1.15) 0.68 0.65 (0.42, 1.01) 0.96 (0.66, 1.40) 0.46 
   ≥1 to <3 months 0.59 (0.42, 0.82) 0.66 (0.43, 1.03)  0.67 (0.46, 0.97) 0.70 (0.44, 1.10)  
  ≥3 to <6 months 0.62 (0.40, 0.98) 0.63 (0.40, 0.99)  0.63 (0.40, 0.99) 0.70 (0.41, 1.17)  
   ≥6 months 0.64 (0.44, 0.93) 0.59 (0.36, 0.97)  0.67 (0.43, 1.03) 0.63 (0.39, 1.01)  
Hazard ratios are from Prentice-weighted Cox proportional hazards models stratified by country and with age as timescale. 
Analyses of parity are conducted in all women; nulliparous women are the reference category. Analyses of breastfeeding are 
conducted in parous women only; parous women with no history of breastfeeding are the reference category. 
Models are adjusted for age at study entry, centre, level of attained education, smoking status, number of live born children 
(for breastfeeding analyses only), high blood pressure, HDL cholesterol, total cholesterol, history of diabetes mellitus, and 
BMI. 
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Figure 3 
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Supplementary Table 1: Baseline characteristics for main variables by EPIC centre 









     Subcohort characteristics 
Country EPIC centre Total, N Subcohort, N CHD, N 








Denmark Aarhus 475 312 170 56.2 (4.4) 29.9 87.2 94.1 
 Copenhagen 1,048 654 408 56.6 (4.3) 37.7 87.9 92.4 
France France 593 557 38 56.4 (6.5) 9.0 90.5 77.2 
Germany Heidelberg 554 489 68 49.3 (8.4) 20.3 81.8 81.8 
 Potsdam 785 709 78 48.7 (9.2) 16.8 90.7 83.7 
Greece Greece 882 766 121 52.6 (12.2) 20.4 90.6 88.3 
Italy Florence 493 420 77 51.6 (7.6) 26.0 85.2 88.2 
 Varese 462 293 173 51.3 (8.2) 21.2 90.4 81.9 
 Ragusa 216 178 39 45.9 (7.9) 23.0 85.4 89.5 
 Turin 271 237 36 51.1 (7.7) 20.3 83.5 72.7 
 Naples 313 223 93 50.1 (7.7) 35.4 91.0 91.6 
Norway Norway 105 60 45 48.7 (4.6) 29.3 93.3 96.4 
Spain Asturias 568 480 96 47.6 (8.1) 19.0 90.6 84.7 
 Granada 526 436 100 49.4 (8.4) 14.5 93.1 90.4 
 Murcia 585 536 56 47.9 (8.5) 18.1 89.4 89.5 
 Navarra 450 410 41 48.6 (7.9) 23.2 85.6 93.1 
 San Sebastian 466 414 59 48.2 (7.9) 18.1 89.6 86.0 
Sweden Malmo 1,765 1,128 679 57.1 (8.0) 28.9 86.9 95.4 
The Netherlands Utrecht 1,761 914 891 57.7 (6.0) 22.0 85.7 82.6 
United Kingdom Cambridge 1,457 523 970 59.0 (9.4) 14.4 87.8 83.3 
 Oxford 1,142 246 900 49.1 (11.6) 6.5 73.6 90.2 
         
Overall  14,917 9,985 5,138 52.7 (9.1) 21.7 87.8 87.2 
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Supplementary Table 2: Hazard ratios (95% confidence intervals) for incident coronary heart disease associated with parity 
and history of breastfeeding in women with complete data on all covariates  
 Model I Model II Model III 
Parity    
  N  14,890 14,319 12,481 
    
Parous (yes vs. no) 1.19 (1.00, 1.40) 1.18 (0.99, 1.40) 1.19 (1.03, 1.38) 
  I
2
 for heterogeneity (95% CI) 60% (21%, 80%) 59% (18%, 80%) 29% (0%, 67%) 
    
Number of children     
   None    
   1 child 1.23 (1.06, 1.42) 1.14 (0.99, 1.31) 1.16 (0.89, 1.51) 
   2 children 1.11 (1.00, 1.23) 1.11 (1.09, 1.13) 1.14 (1.02, 1.28) 
   3 children 1.14 (0.98, 1.32) 1.11 (0.98, 1.25) 1.16 (0.96, 1.41) 
   4 children 1.47 (1.24, 1.75) 1.45 (1.24, 1.70) 1.40 (1.18, 1.66) 
   5 or more children 1.92 (1.34, 2.76) 2.05 (1.30, 3.24) 2.03 (1.27, 3.26) 
    
History of breastfeeding    
  N  12,779 9,466 8,074 
    
Ever breastfed (yes vs. no) 0.68 (0.59, 0.80) 0.61 (0.50, 0.74) 0.70 (0.50, 0.97) 
  I
2
 for heterogeneity 55% (8%, 78%) 61% (16%, 82%) 82% (65%, 91%) 
    
Lifetime duration of breastfeeding     
   Never breastfed 1.00 (0.86, 1.16) 1.00 (0.83, 1.21) 1.00 (0.73, 1.37) 
   >0 to <3 months 0.71 (0.59, 0.84) 0.64 (0.53, 0.77) 0.71 (0.59, 0.86) 
   ≥3 to <6 months 0.67 (0.56, 0.81) 0.62 (0.52, 0.74) 0.67 (0.57, 0.79) 
   ≥6 to <12 months 0.66 (0.59, 0.75) 0.62 (0.55, 0.69) 0.68 (0.55, 0.84) 
   ≥12 to <23 months 0.62 (0.58, 0.67) 0.54 (0.49, 0.59) 0.61 (0.52, 0.71) 
   ≥23 months 0.56 (0.46, 0.70) 0.51 (0.41, 0.65) 0.59 (0.44, 0.79) 
    
Mean duration of breastfeeding per 
child     
   Never breastfed 1.00 (0.93, 1.08) 1.00 (0.84, 1.19) 1.00 (0.74, 1.35) 
   >0 to <1 months 0.79 (0.68, 0.93) 0.68 (0.58, 0.81) 0.82 (0.68, 0.98) 
   ≥1 to <3 months 0.69 (0.64, 0.75) 0.64 (0.57, 0.72) 0.70 (0.65, 0.76) 
  ≥3 to <6 months 0.59 (0.49, 0.71) 0.59 (0.52, 0.67) 0.69 (0.60, 0.80) 
   ≥6 months 0.56 (0.47, 0.67) 0.58 (0.50, 0.67) 0.66 (0.57, 0.77) 
27 individuals with no follow-up were excluded from the analyses. Hazard ratios are from Prentice-weighted Cox proportional 
hazards models stratified by country and with age at study entry as timescale. Analyses of parity are conducted in all women. 
Analyses of breastfeeding are conducted in parous women only.  
Model I: Adjusted for age at study entry and centre; Model II: model I + level of attained education, smoking status, and 
number of live born children (for breastfeeding analyses only); Model III: model II + high blood pressure, HDL cholesterol, 
total cholesterol, history of diabetes mellitus, and BMI.  
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Supplementary Table 3: Hazard ratios (95% confidence intervals) for incident coronary heart disease associated with parity 
and history of breastfeeding in women aged 45 years or older at study entry 
 Model I Model II Model III 
Parity    
  N  12,608 12,049 10,351 
    
Parous (yes vs. no) 1.19 (1.00, 1.42) 1.19 (1.01, 1.41) 1.19 (1.01, 1.39) 
  I
2
 for heterogeneity (95% CI) 62% (24%, 81%) 55% (8%, 78%) 38% (0%, 72%) 
    
Number of children     
   None 1.00 (0.82, 1.22) 1.00 (0.85, 1.18) 1.00 (0.85, 1.18) 
   1 child 1.26 (1.11, 1.44) 1.18 (1.01, 1.37) 1.19 (0.93, 1.53) 
   2 children 1.11 (1.04, 1.18) 1.13 (1.11, 1.15) 1.13 (1.02, 1.26) 
   3 children 1.15 (0.98, 1.36) 1.14 (1.01, 1.28) 1.15 (0.95, 1.40) 
   4 children 1.50 (1.21, 1.86) 1.51 (1.28, 1.79) 1.40 (1.17, 1.67) 
   5 or more children 1.91 (1.34, 2.71) 2.02 (1.29, 3.15) 2.03 (1.27, 3.27) 
    
History of breastfeeding    
  N  10,832 8,307 6,998 
    
Ever breastfed (yes vs. no) 0.69 (0.59, 0.81) 0.61 (0.50, 0.76) 0.71 (0.51, 1.00) 
  I
2
 for heterogeneity 58% (15%, 79%) 66% (27%, 84%) 83% (66%, 91%) 
    
Lifetime duration of 
breastfeeding     
   Never breastfed 1.00 (0.89, 1.13) 1.00 (0.81, 1.24) 1.00 (0.72, 1.38) 
   >0 to <3 months 0.70 (0.60, 0.82) 0.64 (0.51, 0.80) 0.71 (0.57, 0.87) 
   ≥3 to <6 months 0.68 (0.60, 0.79) 0.61 (0.50, 0.75) 0.69 (0.58, 0.82) 
   ≥6 to <12 months 0.70 (0.58, 0.84) 0.63 (0.56, 0.70) 0.70 (0.57, 0.86) 
   ≥12 to <23 months 0.65 (0.57, 0.74) 0.55 (0.50, 0.61) 0.64 (0.54, 0.75) 
   ≥23 months 0.59 (0.46, 0.76) 0.50 (0.38, 0.65) 0.61 (0.45, 0.82) 
    
Mean duration of breastfeeding 
per child     
   Never breastfed 1.00 (0.90, 1.11) 1.00 (0.83, 1.21) 1.00 (0.73, 1.37) 
   >0 to <1 months 0.79 (0.67, 0.94) 0.67 (0.56, 0.81) 0.82 (0.67, 1.01) 
   ≥1 to <3 months 0.71 (0.67, 0.75) 0.66 (0.59, 0.73) 0.73 (0.68, 0.79) 
  ≥3 to <6 months 0.61 (0.50, 0.74) 0.61 (0.53, 0.69) 0.71 (0.62, 0.83) 
   ≥6 months 0.59 (0.49, 0.72) 0.59 (0.51, 0.69) 0.70 (0.60, 0.81) 
Hazard ratios are from Prentice-weighted Cox proportional hazards models stratified by country and with age at study entry 
as timescale. Analyses of parity are conducted in all women. Analyses of breastfeeding are conducted in parous women only. 
Model I: Adjusted for age at study entry and centre; Model II: model I + level of attained education, smoking status, and 
number of live born children (for breastfeeding only); Model III: model II + high blood pressure, HDL cholesterol, total 
cholesterol, history of diabetes mellitus, and BMI.  
